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ABSTRACT
Liver metastases are commonly found in advanced cancer patients; however, acute liver failure secondary to diffuse liver 
infiltration is rare. Small cell lung carcinoma accounts for 15% of lung carcinomas. We describe the ninth case of small 
cell lung carcinoma massively metastatic to the liver, reported in the scientific literature, with sudden clinical onset and 
death after a few days. An autopsy was performed to understand the cause of death. 
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INTRODUCTION
Small cell lung carcinoma (SCLC) is an aggressive 
neuroendocrine neoplasia, which is strongly related 
to smoking attitude, characterized by rapid growth 
and very poor overall survival, usually diagnosed as 
a central tumor.1 It accounts for 13-15% of all lung 
cancers and represents the sixth most common cause 
of death for malignant tumours.2
Histological evaluation is mandatory. According 
to the World Health Organization (WHO), morphology 
and immunohistochemistry should be performed for 
the final diagnosis.3
The lack of specific symptoms at early tumor stages 
and the lack of screening methods continue to be the 
main obstacles for the early detection of this disease. 
Most patients are diagnosed with advanced disease—
often with a metastatic dissemination (extensive 
stage [ES]).4 Because of the highly progressed disease 
states, clinical courses are usually too short to identify 
the causes, resulting in multi-organ failure.
We describe the unusual case of an occult SCLC with 
clinical onset for jaundice and fulminant progression up 
to death within a few days. The particularities of the 
case are also its incidental diagnosis at autopsy, clinical 
onset with non-obstructive jaundice liver disease, and 
the rapid progression towards death.
To date 35 cases (in 25 papers) of SCLCs with 
diffuse liver metastases and fulminant liver failure have 
been described in the medical literature, but in 9 cases 
the clinical onset was sudden and without warning, 
followed by a quick death.
We will carry out a critical review of all published cases.
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CASE REPORT
A 78-year-old male, who was a heavy smoker, 
presented at the Emergency Department with 
recently appeared jaundice (sclera and skin) and lower 
limbs edema. Past medical history included chronic 
obstructive pulmonary disease and hypertensive 
heart disease. He had no history of hepatitis, alcohol 
abuse, or drug allergy. On admission, the physical 
examination revealed a globose abdomen with 
marked hepatomegaly, respiratory examination was 
consistent with chronic bronchitis with mild dyspnea 
and shortness of breath.
An  abdomina l  and  tho ra c i c  computed 
tomography was performed and showed a lesion 
in the lower lobe of the right lung highly suspicious 
of malignancy, and marked hepatomegaly not 
otherwise specified.
Due to severe renal, cardiac, and hepatic 
conditions, the patient was hospitalized in intensive 
care. The patient developed hepatic encephalopathy 
and later went into a coma. He died with acute liver 
failure (ALF) and multi-organ failure only 7 days after 
admission.
AUTOPSY PRESENTATION
The Autopsy Revealed Unexpected Findings
The liver (Figure 1) extended from the right to the 
left hipochondrium.
The liver’s dimensions had increased so much that 
it could be measured from the costal arch of 14 cm on 
the right and 6 cm on the left. The liver weighed 4.25 kg 
(Reference range [RR]; 1.5 kg) and the cut surface was 
entirely occupied by small yellowish-white nodules of 
varying sizes (average size of 0.3-0.4 cm). Moderate ascitic 
fluid (approx. 400 mL) was present. There was evidence of 
bilateral pulmonary edema, and lower limbs edema. In the 
right lower pulmonary lobe (Figure 2) there was a yellowish-
white nodule of 5.5 cm, which involved bronchial branches. 
There were bilateral lymphadenopathies; the ipsilateral 
major lymph node measured 1.9 cm. The left ventricle 
hypertrophy (wall thickness of the left ventricle of 2.3 cm) 
was compatible with hypertensive heart disease. No brain 
lesions were identified and the other organs did not show 
remarkable changes.
Figure 1. Gross view the liver. A – the outer surface is 
completely covered by small nodular lesions; B – multiple 
cross-sections showing the hepatic parenchyma 
completely occupied by yellowish-white nodules, with 
an average diameter of 3-4 mm.
Figure 2. Gross view of lung tumor. A whitish 
5.5 cm nodule was found in the right lower lobe, with 
peribronchial growth.
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cells were strongly and diffusely positive for cytokeratin 
cocktail MNF116, CD56, and TTF-1, and faintly positive 
for synaptophysin and chromogranin A.
Three Ipsilateral Peribronchial Lymph Nodes 
Revealed SLCL Metastases
The liver was enlarged due to massive SLCL 
infiltration, which was also responsible by the 
cholestasis (Figures 4 and 5).
Figure 3. Photomicrographs of the lung neoplasm (A – H&E, 40X; B – H&E, 200X). The lesion histology consisted of small, 
rounded to oval, tumor cells, diffusely overlapped with diffused growth, with granular chromatin, nucleolus absent.
The Tissues Were Fixed in 10% Neutral Formalin 
and Embedded in Paraffin
The pulmonary les ion (F igure 3)  was an 
undifferentiated lymphocytic-like neoplasm, mainly of 
small cells, with nuclear characteristics (salt and pepper 
chromatin), which allowed the diagnosis of small 
cell carcinoma. The immunohistochemical findings 
confirmed a small cell carcinoma; in fact, these tumor 
Figure 4. Photomicrographs of liver infiltrated by small cell lungs carcinoma (A – H&E, 40X; B – H&E, 100X; C – H&E, 200X; 
D – H&E, 40X). The liver was massively infiltrated by the lung neoplasm; only thin cords of hepatocytes remained.
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No signs of portal hypertension was found. 
The spleen was small (weighed 70g, mean RR; 112g), 
and was histologically normal.
The Remaining Organs Were Free of Neoplastic 
Infiltration
Based on the gross and microscopic features and 
the clinical picture, the cause of the patient’s death 
might therefore be placed as: “ALF and multi-organic 
damage associated with the hepato-renal syndrome 
in SCLC with massive hepatic infiltration.”
DISCUSSION
Most studies regarding fulminant hepatic failure 
in metastatic liver SCLC have been published as case 
reports. To our knowledge, in 25 scientific papers a 
total of 35 cases of hepatic failure due to metastatic 
SCLC were reported (see Table 1).
An autopsy was performed in 24 of the 
35 published cases.5-29
Apart from our case, only 10 others have been 
described with sudden onset and death within a few 
days. In 8 of these 10 cases, an autopsy was performed. 
In this type of case, performing an autopsy is of 
paramount importance to understand the causes of 
death. Let us consider these eight cases and compare 
them with ours.
The lung tumors (when measured) in these cases 
were large, from a minimum of 14 mm29 to a maximum 
of 48 mm;26 in our case it measured 55 mm and was 
the largest ever described, yet it remained clinically 
silent.
In the other 35 reported cases, the liver weight 
ranged between 1.4 and 8.2 kg;21,27 in our case, the 
liver weighed 4.25 kg.
In the other cases, death occurred after a minimum 
of 1 hour22 from the time of arrival in the hospital to 
Figure 5. Photomicrographs of liver infiltrated by small cell lung carcinoma. A – the rare waves of residual 
hepatocytes are evident (Hep Par 1 immunohistochemical stain, 200X); B – the extensive aggregates of neoplastic 
cells that destroy the hepatic structure are evident (CD56 immunohistochemical stain 200X); C – faint positivitity for 
Chromogranin (200X); D – faint positivitity for Synaptophysin (400X).
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Table 1. Summary of previously reported cases and the index case of acute hepatic failure due to metastatic SCLC
Authors
Time from 
admission 
to death
Autopsy Age y Sex
Pulmonary 
lesion size
Liver weight 
kg
Clinical 
onset
Other metastases
Watson5 14 d Yes 48 M NA 3.7 2 m Hilar, tracheo-bronchial 
lymph-nodes, bone marrow
14 d Yes 59 M NA 4.76 S tracheo-bronchial lymph 
nodes. porta hepatis and 
supra-pancreatic nodes
6 d Yes 45 M NA 2.4 S Pleural effusion, bone 
marrow
Few days Yes 40 M NA 4.16 2 m Mediastinal lymph nodes, 
pleurae, pericardium, 
retroperitoneal lymph-nodes
NA Yes 59 M large ME 5 m hilar lymph nodes, spleen
Spechler et al.6 9 d Yes 57 M 20 mm H 6 w No
6 d Yes 52 M extensive H 8 m Pleural
Harrison et al.7 6 d Yes 64 M 50 mm 4.3 3 w No
Wesbey8 10 d Yes 79 M NA NA S NA
5 d Yes 55 NA NA EM 8m NA
Sheriff9 – Yes 57 – – EM Some 
months
–
McGuire et al.10 8 d No 68 M 20 mm H 1 w No
1 d No 66 M Small E 1 m No
2 d Yes 58 F NA 5.1 2 w Mediastinal lymph node
9 d No 51 M 20 mm mH 2w No
Galus11 9 d Yes 46 F – 5.2 S –
Ihara et al.12 20 d Yes 65 M small mH NA No
Kovalev et al.13 4 d No 77 F small H 5 d Pleural effusion
Athanasakis et al.14 5 d No 68 M 50 mm H 20 d no
Rajvanshi et al.15 9 d Yes 77 M small 3.4 3 w No
Alexopoulou et al.16 7 d No 61 M NA H 10 d NA
Kaira et al.17 >182 d No 69 M – – 2 w No
Hwang et al.18 15 d No 69 F Ill-defined 
mass
H 5 w Mediastinal nodes 
enlargement
Gilbert et al.19 4 d Yes 54 M 32 mm 5.2 4 d Lung, bone, lymph nodes, 
spinal soft tissue
Richecoeur et al.20 4 d No 66 M 20 mm hepatomegaly S NA
Miyaaki et al.21 7 d Yes 62 F small 3.55 S No
Vaideeswar et al.22 1 h Yes 69 M 40 mm 1.4 S Hilar lymph nodal/bone 
marrow metastases
Sato et al.23 7 d Yes 69 M NA 3,57 1 m Lungs, kidneys, adrenals, 
spleen, vertebrae
8 d Yes 69 M NA 2.7 S NA
Ke et al.24 10 d No 75 F – H 5 w Mediastinal 
lymphadenopathy
Mishima et al.25 13 d No 63 M 15 mm – 1 y –
Maglantay et al.26 5 d Yes 90 M 48 mm 2.98 5 d No
Fodor et al.27 7 hours Yes 78 M 10 mm 6.5 3 m Lymph nodes, iliac crest 
bone marrow, synchronous 
prostate adenocarcinoma
Mitselou et al.28 Few days Yes 59 M 25 mm 8.2 S Lymph node
Arif et al.29 10 d No 75 F 14 mm H S No
This study 7 d Yes 78 M 55 mm 4.25 S Three ipsilateral 
peribronchial lymph nodes
D = days; E = enlarged; EM = extensive metastases; F = female; H = hepatomegaly; M = male; ME = moderately enlarged; 
NA = not available; S = sudden; SCLC = small cell lung carcinoma; y = year.
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a maximum of 14 days5 (average of 7.1 days); in our 
case death occurred 7 days after hospitalization.
The liver is the most common site for metastatic 
tumor deposits with evidence of hepatic metastases 
reported in 36% of all patients who died from cancer.30 
Despite this, liver dysfunction may not be evident. 
Fulminant hepatic failure (FHF; also known as ALF) 
secondary to a metastatic tumor is rare. In some cases, 
tumors may replace up to 90% of the liver without 
any manifestation of jaundice. However drowsiness 
and abdominal pain have been reported.
Small cell lung cancer is so highly invasive that 
hepatic metastasis is common, but a rapid progression 
to ALF is extremely rare. In most patients with ALF 
secondary to malignant infiltration of the liver, the 
prognosis is terrible.
In cases of very rapid progression from the time 
of clinical onset, the cause of hepatomegaly may be 
unknown at the time of the patient’s death.
CONCLUSION
Each case of ALF of undetermined etiology 
must be evaluated with a high index of suspicion. 
The aggressiveness of SCLC is well documented and, 
in many cases, metastatic lesions are diagnosed prior to 
the discovery of the primary tumor. In hepatomegaly, 
imaging is often non-diagnostic. In order to suggest 
which therapies to follow, liver biopsy must be 
considered in indeterminate cases.
Diffuse liver metastasis must be considered when 
imaging modalities show hepatomegaly in patients 
with FHF, especially when viral hepatitis and drug 
reactions are excluded. It is therefore of paramount 
importance for the clinician to take hepatomegaly into 
consideration in the investigation of distant metastases 
of unknown primary origin.
The role of the autopsy in this type of case is 
fundamental.
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